NYSE · TDOC

Teladoc Health, Inc.

$9.15 +$0.38 (+4.33%) 1D Market open

Key Metrics

$1.58B
Market cap
P/E · TTM
$2.51B
Revenue · TTM
−$171.15M
Net income
EPS · TTM $-0.98
Dividend yield
Free cash flow $280.13M
Beta · 1Y 1.59
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 28
    The stock moved +14.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 28
  • Feb 26
    The stock moved +15.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 26

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.58B
Enterprise value
Shares outstanding180.5M
52-wk range$4.40 – $9.89
Avg volume · 20D5.1M
Net cash
Book value / share$7.67
IndustryServices-Offices & Clinics Of Doctors Of Medicine
ExchangeNYSE
About Teladoc Health, Inc.
IPO dateJul 1, 2015
Employees5600

Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.63
P/FCF5.65
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating -7.4%
Net -6.8%
FCF 11.1%
ROE / ROIC -12.1% · -29.2%

Financial Health

Current ratio2.80
Quick ratio2.72
Debt / equity
Debt / EBITDA
Net cash
Working capital$727.47M

Cash Flow · TTM

Operating CF $287.95M
Capex −$7.83M
Free cash flow $280.13M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

-6.6
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings